|
Do Premarin® and
Provera® Increase Breast Cancer Risk?
YES! On July 9, 2002, the results of the Women’s Health
Initiative made front page news.
The study was
performed by the National Institute of Health and was designed
to be completed over 10 years to answer the following: Does hormone
replacement, (Premarin and Provera) increase a woman’s risk
of breast cancer and do the benefits of treatment outweigh the
risk?
After only five years,
the results were so overwhelming the study was stopped. The risk
of breast cancer in the women in the study, was increased by 26%.
This number may have been higher, since 42% of the women, who
were selected to take the Premarin and Provera, refused to continue
in the study because they could not tolerate the side effects.
Not only
did Premarin and Provera increase the risk of breast cancer, but
it also increased the risk of heart disease by 29%, stroke by
41%, Alzheimer’s Dementia by 200%, and blood clots to the
lung by 213%.
The results of
the study were surprising to most physicians. Estrogen has been
prescribed to women without appropriate testing for many years.
Most women have normal or high free estrogen levels during menopause;
therefore, prescribing estrogen to these women has been detrimental.
Provera,
which it is not chemically the same as progesterone, does not
have the beneficial effects of progesterone. Provera actually
blocks progesterone from having its positive effect by binding
to the area of the cell reserved for progesterone.
Provera
usually causes weight gain, bloating, depression,
hair loss, and increased risk of breast cancer, while progesterone
does the exact opposite.
What should women do who
are taking Premarin and Provera or any other estrogen/progestin
combination? First have your estrogen levels checked through saliva
testing. Taper off the estrogen over several months if your estrogen
levels are high. You can stop the Provera and use natural progesterone
to aintain an appropriate estrogen/ progesterone ratio. The book
“Are Your Hormones Making You Sick” will give you
information to guide you to healthy hormonal balance. The doctor
or pharmacist who gave you this newsletter can help you achieve
and maintain hormonal balance.
Progesterone and Breast Cancer Prevention
Estrogen
stimulates cell growth. Progesterone slows cell growth and encourages
normal cell development. Estrogen and progesterone should be in
balance with each other. If there is |
|
more estrogen than
progesterone available to the breast cell, it will grow, but not
develop normally. Progesterone has been shown to decrease normal
breast cell growth and to slow the growth of cancer cells in the
breast and uterus.
Progesterone can slow
cell growth, even if the cells are exposed to estrogen. In one
study, women were given estrogen cream and another group progesterone
cream. The number of cells replicating in the estrogen group was
10 times greater than in the progesterone group. Women in the
third group received both estrogen and progesterone and their
cell growth was normal.
Another study
done at Johns Hopkins Medical School revealed that women with
progesterone deficiency were 5.4 times more likely to develop
breast cancer prior to menopause. It appears that an adequate
amount of progesterone is needed to balance the effects of estrogen
exposure, which stimulates cancer growth.
As women reach
perimenopause (35-50 years old) progesterone declines and estrogen
increases, due to irregular ovulation. Excess estrogen and decreased
progesterone may cause PMS, irregular bleeding, fibroid growth,
and weight gain during this time in a woman’s life. A decline
in progesterone may explain why breast cancer in this age group
is more aggressive and fatal.
Salivary testing
can determine whether or not estrogen and progesterone are in
balance. Supplementing with bioidentical progesterone, along with
dietary and lifestyle changes in conjunction with appropriate
supplements, can decrease your estrogen exposure, thereby greatly
decreasing your risk of breast cancer.
If you have
breast cancer , progesterone can be used as a hormone replacement
to alleviate hot flashes. Studies have shown that natural progesterone
applied to the skin will alleviate menopausal symptoms in 83 %
of women. Estrogen is contraindicated in anyone who has breast
cancer while progesterone is safe and does not increase a woman’s
risk of recurrence of breast cancer. Progesterone is not contraindicated
in breast cancer survivors.
|